434 related articles for article (PubMed ID: 14673218)
1. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
Sheehan DV; Rozova A; Gossen ER; Gibertini M
Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
[TBL] [Abstract][Full Text] [Related]
3. Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta database.
Saletu B; Prause W; Anderer P; Mandl M; Aigner M; Mikova O; Saletu-Zyhlarz GM
Neuropsychobiology; 2005; 51(3):148-63. PubMed ID: 15838186
[TBL] [Abstract][Full Text] [Related]
4. [Current treatment of depression and agitation in the elderly -- clinical use of trazodone].
Osváth P
Neuropsychopharmacol Hung; 2013 Sep; 15(3):147-55. PubMed ID: 24108179
[TBL] [Abstract][Full Text] [Related]
5. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
Perugi G; Frare F; Toni C; Ruffolo G; Torti C
Neuropsychobiology; 2002; 46(3):145-9. PubMed ID: 12422062
[TBL] [Abstract][Full Text] [Related]
6. Insomnia treatment in the third trimester of pregnancy reduces postpartum depression symptoms: a randomized clinical trial.
Khazaie H; Ghadami MR; Knight DC; Emamian F; Tahmasian M
Psychiatry Res; 2013 Dec; 210(3):901-5. PubMed ID: 23993464
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of prolonged-release trazodone in major depressive disorder: a multicenter, randomized, double-blind, flexible-dose trial.
Zhang L; Xie WW; Li LH; Zhang HG; Wang G; Chen DC; Cao Y; Cui LJ; Zhang KR; Shi JG; Tan QR; Zheng HB; Xu XF; Cheng ZH; Zhao JP
Pharmacology; 2014; 94(5-6):199-206. PubMed ID: 25376160
[TBL] [Abstract][Full Text] [Related]
8. [Trazodone Contramid® in clinical practice: personalizing antidepressant intervention].
Fagiolini A; Amodeo G; Goracci A; Blardi P
Riv Psichiatr; 2016; 51(4):123-128. PubMed ID: 27727261
[TBL] [Abstract][Full Text] [Related]
9. Open pilot study of gabapentin versus trazodone to treat insomnia in alcoholic outpatients.
Karam-Hage M; Brower KJ
Psychiatry Clin Neurosci; 2003 Oct; 57(5):542-4. PubMed ID: 12950711
[TBL] [Abstract][Full Text] [Related]
10. Patients with insomnia and subthreshold depression show marked worsening of insomnia after discontinuation of sleep promoting medication.
Wichniak A; Wierzbicka A; Jernajczyk W
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1671-6. PubMed ID: 21723905
[TBL] [Abstract][Full Text] [Related]
11. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
Munizza C; Olivieri L; Di Loreto G; Dionisio P
Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations.
Le Bon O; Murphy JR; Staner L; Hoffmann G; Kormoss N; Kentos M; Dupont P; Lion K; Pelc I; Verbanck P
J Clin Psychopharmacol; 2003 Aug; 23(4):377-83. PubMed ID: 12920414
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of trazodone in the treatment of insomnia].
Gałecki P; Florkowski A; Talarowska M
Pol Merkur Lekarski; 2010 Jun; 28(168):509-12. PubMed ID: 20642116
[TBL] [Abstract][Full Text] [Related]
14. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone.
Saletu-Zyhlarz GM; Abu-Bakr MH; Anderer P; Gruber G; Mandl M; Strobl R; Gollner D; Prause W; Saletu B
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):249-60. PubMed ID: 11817501
[TBL] [Abstract][Full Text] [Related]
15. Trazodone addition for insomnia in venlafaxine-treated, depressed inpatients: a semi-naturalistic study.
Bertschy G; Ragama-Pardos E; Muscionico M; Aït-Ameur A; Roth L; Osiek C; Ferrero F
Pharmacol Res; 2005 Jan; 51(1):79-84. PubMed ID: 15519538
[TBL] [Abstract][Full Text] [Related]
16. [Personalized treatment of depression phenotypes: role of trazodone in depression with insomnia].
Antonelli Incalzi R; Caraci F; Cuomo A; Fagiolini A; Ferini Strambi L
Riv Psichiatr; 2020; 55(6):371-379. PubMed ID: 33349731
[TBL] [Abstract][Full Text] [Related]
17. Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: pharmacology and clinical practice.
Cuomo A; Ballerini A; Bruni AC; Decina P; Di Sciascio G; Fiorentini A; Scaglione F; Vampini C; Fagiolini A
Riv Psichiatr; 2019; 54(4):137-149. PubMed ID: 31379379
[TBL] [Abstract][Full Text] [Related]
18. Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients.
Scharf MB; Sachais BA
J Clin Psychiatry; 1990 Sep; 51 Suppl():13-7. PubMed ID: 2211559
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of trazodone retard monotherapy: results of the Serbian non-interventional study.
Miljevic CD; Lečić-Toševski D; Trazodone Study Group Serbia
Int J Psychiatry Clin Pract; 2016 Sep; 20(3):133-40. PubMed ID: 27335239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
